Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 07/02/2020
Closing price: 258.24
| Support price level: | $235.40 |
| Resistance price level: | N/A |
| Relative strength index (14-day RSI) | 81.2 |
| Beta | 0.27 |
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 36.9 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- AMGN is one of this month's top performers with a return of 16.9 percent, beating 90 percent of stocks in the S&P-100.
- Up 9.8 percent, AMGN is one of this week's biggest gainers.
- The price of this low-beta stock is expected to increase by 0.27% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Low | High | Price as % of Range |
| $174.11 | $258.24 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
| $221.50 | $231.76 | $231.65 | $238.99 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 26.4% | 28.1% | 39.0% | 30.3% |
- 10.6% in the next week.
- 17.1% in the next month.
- 61.5% in the next year.
